Mindray Medical International Limited’s (MR) MACD indicator has moved into bearish territory with a reading of -0.001. The Zacks #4 Rank (“Sell”) stock was up slightly at $28.31 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending December 2010 has decreased by 1 cent over the past month to $1.39 per share.
 
MINDRAY MEDICAL (MR): Free Stock Analysis Report
 
Zacks Investment Research